Diplomat to Host Analyst and Investor Day on June 27, 2017

Tuesday, May 23, 2017 Research News
Email Print This Page Comment
Font : A-A+

FLINT, Mich., May 22, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) will be hosting its second Analyst and Investor

Day on Tuesday, June 27, 2017 in New York City.

The nation's largest independent provider of specialty pharmacy services will provide industry insight and outline strategies for

how the company will drive long-term growth and shareholder value. Panel discussions will feature external pharmaceutical manufacturer, payor, and consultant business partners and Diplomat executives.

A live audio-only webcast of Diplomat's Analyst and Investor Day and related presentation materials will be available on the investor relations section of the company's website at ir.diplomat.is. Following the event, presentation materials and an audio file will be archived for 90 days at ir.diplomat.is.

About Diplomat Diplomat (NYSE: DPLO) is the nation's largest independent provider of specialty pharmacy services—helping patients and providers in all 50 states. The company offers medication management programs for people with complex chronic diseases and delivers unique solutions for manufacturers, hospitals, payors, providers, and more. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.

INVESTOR CONTACT: Bob East, Westwicke Partners 443.213.0500 | diplomat@westwicke.com

MEDIA CONTACT: Jenny Cretu, Diplomat 810.768.9370 | jcretu@diplomat.is 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/diplomat-to-host-analyst-and-investor-day-on-june-27-2017-300461541.html

SOURCE Diplomat Pharmacy, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook